These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6117062)

  • 1. Central neural peptides and catecholamines in spontaneous and DOCA/salt hypertension.
    Morris M; Wren JA; Sundberg DK
    Peptides; 1981; 2(2):207-11. PubMed ID: 6117062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between enkephalinergic neurons and the vasopressin-oxytocin neuroendocrine system of the cat: an immunohistochemical study.
    Micevych P; Elde R
    J Comp Neurol; 1980 Mar; 190(1):135-46. PubMed ID: 6991553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain catecholamines in spontaneously hypertensive and DOCA-salt hypertensive rats.
    Fujino K
    Acta Med Okayama; 1984 Aug; 38(4):325-40. PubMed ID: 6149670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine biosynthesis and vasopressin and oxytocin secretion in the spontaneously hypertensive rat: an in vitro study of localized brain regions.
    Morris M; Ross J; Sundberg DK
    Peptides; 1985; 6(5):949-55. PubMed ID: 4080611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of hypophysiotropic peptides and other biologically active peptides within the brain.
    Elde R; Hökfelt T
    Annu Rev Physiol; 1979; 41():587-602. PubMed ID: 107852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM; Westfall TC
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium, vasopressin receptors, and resistance to DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H15-21. PubMed ID: 8342627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of catecholamines in central and peripheral tissues and in the urines of deoxycorticosterone--salt hypertensive rats.
    Buu NT; Kuchel O; Genest J
    Can J Physiol Pharmacol; 1983 Aug; 61(8):888-92. PubMed ID: 6627129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in paraventricular vasopressin and oxytocin during the development of spontaneous hypertension.
    Morris M; Keller M; Sundberg DK
    Hypertension; 1983; 5(4):476-81. PubMed ID: 6862574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of naloxone on the release of neurohypophysial hormones in normotensive and spontaneously hypertensive rats.
    Rosella-Dampman LM; Emmert SE; Keil LC; Summy-Long JY
    Brain Res; 1985 Jan; 325(1-2):205-14. PubMed ID: 3978414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone (TRH) modifies oxytocin release from the hypothalamo-neurohypophysial system in salt-loaded rats.
    Ciosek J; Stempniak B
    J Physiol Pharmacol; 1995 Jun; 46(2):169-77. PubMed ID: 7670125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain catecholamines during development of DOCA-salt hypertension in rats.
    Saavedra JM
    Brain Res; 1979 Dec; 179(1):121-7. PubMed ID: 509225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of magnocellular vasopressin mRNA in rats with deoxycorticosterone-acetate induced salt appetite.
    Grillo CA; Saravia F; Ferrini M; Piroli G; Roig P; García SI; de Kloet ER; De Nicola AF
    Neuroendocrinology; 1998 Aug; 68(2):105-15. PubMed ID: 9705577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of thyroliberin (TRH) on hypothalamo-neurohypophysial vasopressin and oxytocin content of rats drinking 2% NaCl.
    Ciosek J
    Patol Pol; 1993; 44(4):221-6. PubMed ID: 8309734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperresponsiveness of sympathoadrenal system in conscious DOCA-NaCl and SHR rats in response to acute hemorrhagic hypotension.
    Drolet G; de Champlain J
    Clin Invest Med; 1992 Aug; 15(4):360-70. PubMed ID: 1516293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.